Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online November 15, 2018.
Article Versions
- You are currently viewing a previous version of this article (November 15, 2018 - 02:42).
- View the most recent version of this article
Copyright & Usage
Copyright ©ERS 2018
Author Information
- Luca Richeldi1,2,
- Sophie Fletcher2,3,
- Huzaifa Adamali4,
- Nazia Chaudhuri3,5,
- Sabrina Wiebe6,
- Sven Wind6,
- Kathrin Hohl6,
- Andrew Baker7,
- Rozsa Schlenker-Herceg8,
- Susanne Stowasser9 and
- Toby M. Maher3,10
- 1Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli, Rome, Italy
- 2Department of Respiratory Medicine, University Hospital Southampton and Southampton NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, United Kingdom
- 3Translational Research Collaboration – Inflammatory Respiratory Disease Centre, United Kingdom
- 4Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Southmead Hospital, Bristol, United Kingdom
- 5North West Lung Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom
- 6Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
- 7Boehringer Ingelheim Ltd, Bracknell, UK
- 8Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA
- 9Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
- 10National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, and Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, United Kingdom
- Professor Luca Richeldi, Unità Operativa Complessa di Pneumologia, Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli, Largo Agostino Gemelli 8, 00168 Roma, Italy. E-mail: luca.richeldi{at}unicatt.it
Funding
Boehringer Ingelheim